首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer.
【24h】

Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer.

机译:子宫颈腔内近距离放射治疗中基于MRI的治疗计划的剂量和体积参数。

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: Magnetic resonance imaging (MRI)-based treatment planning in intracavitary brachytherapy allows optimization of the dose distribution on a patient-by-patient basis. In addition to traditionally used point dose and volume parameters, dose-volume histogram (DVH) analysis enables further possibilities for prescribing and reporting. This study reports the systematic development of our concept applied in clinical routine. Methods and Materials: A group of 22 patients treated with 93 fractions using a tandem-ring applicator and MRI-based individual treatment planning for each application was analyzed in detail. High-risk clinical target volumes and gross tumor volumes were contoured. The dose to bladder, rectum, and sigma was analyzed according to International Commission of Radiation Units and Measurements (ICRU) Report 38 and DVH parameters (e.g., D(2cc) represents the minimal dose for the most irradiated 2 cm(3)). Total doses, including external beam radiotherapy and the values for each individual brachytherapy fraction, were biologically normalized to conventional 2-Gy fractions (alpha/beta 10 Gy for target, 3 Gy for organs at risk). Results: The total prescribed dose was about 85 Gy(alphabeta10), which was mainly achieved by 45 Gy external beam radiotherapy plus 4 x 7 Gy brachytherapy (total 84 Gy(alphabeta10)). The mean value was 82 Gy(alphabeta10) for the point A dose (left, right) and 84 cm(3) for the volume of the prescribed dose. The average dose to the clinical target volume was 66 Gy(alphabeta10) for the minimum target dose, 87 Gy(alphabeta10) for the dose received by at least 90% of the volume, with a mean volume treated with at least the prescribed dose of 89%. The mean D(2cc) for the bladder was 83 Gy(alphabeta3), the ICRU point dose was 75 Gy(alphabeta3), and the dose at the ICRU point plus 1.5 cm cranially was 100 Gy(alphabeta3). The average dose to the rectum was 64 Gy(alphabeta3) for D(2cc) and at ICRU point 69 Gy(alphabeta3). The sigma D(2cc) was 63 Gy(alphabeta3). Conclusion: A standard loading pattern should be used as the starting point for MRI-based optimization. Individual changes of active dwell positions and dwell weights are guided by a concept of DVH constraints for target and organs at risk. In our clinical routine, the dose to point A and dose received by at least 90% of the volume for the clinical target volume are both comparable to the prescribed dose. The DVH constraints for organs at risk allow reproducible treatment plans, helping to detect and avoid severe overdosage.
机译:目的:腔内近距离放射治疗中基于磁共振成像(MRI)的治疗计划可在逐个患者的基础上优化剂量分布。除传统使用的点剂量和体积参数外,剂量体积直方图(DVH)分析还为处方和报告提供了更多可能性。这项研究报告了我们在临床常规中应用的概念的系统发展。方法和材料:使用串联环涂药器和基于MRI的个体治疗计划对22例使用93馏分治疗的患者进行了详细分析。概述了高风险的临床目标体积和肿瘤总体积。根据国际辐射单位和测量委员会(ICRU)报告38和DVH参数分析了膀胱,直肠和西格玛的剂量(例如,D(2cc)代表照射最多2 cm(3)的最小剂量)。将总剂量(包括外部射线放疗和每个近距离放射治疗分数的值)生物学上标准化为常规的2-Gy分数(靶标为alpha / beta 10 Gy,有风险的器官为3 Gy)。结果:总处方剂量约为85 Gy(alphabeta10),这主要是通过45 Gy体外束放射疗法加4 x 7 Gy近距离放射疗法(总共84 Gy(alphabeta10))实现的。 A点剂量(左,右)的平均值为82 Gy(alphabeta10),规定剂量的体积平均值为84 cm(3)。最小目标剂量的临床目标体积的平均剂量为66 Gy(alphabeta10),接受剂量的至少90%的体积为87 Gy(alphabeta10),且平均体积至少用指定剂量的89%。膀胱的平均D(2cc)为83 Gy(alphabeta3),ICRU点剂量为75 Gy(alphabeta3),ICRU点加颅骨1.5 cm处的剂量为100 Gy(alphabeta3)。 D(2cc)的直肠平均剂量为64 Gy(alphabeta3),ICRU点的平均剂量为69 Gy(alphabeta3)。 Sigma D(2cc)为63 Gy(alphabeta3)。结论:应将标准加载模式用作基于MRI的优化的起点。有效驻留位置和驻留权重的个体变化以针对目标和处于风险中的器官的DVH约束的概念为指导。在我们的临床常规中,A点的剂量和临床目标体积的至少90%的剂量均与处方剂量相当。 DVH对有风险器官的限制允许可重复的治疗计划,有助于发现并避免严重的用药过量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号